Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 1, 1999, Pages 48-52

  Harris, David ^a   Kendall, David A ^a   Randall, Michael D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

AM630; Cannabinoids; Endothelium; Endothelium derived hyperpolarizing factor (EDHF); LY320135; SR144528

Indexed keywords

4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; 6 IODOPRAVADOLINE; CANNABINOID RECEPTOR; CARBACHOL; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; LEMAKALIM; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; UNCLASSIFIED DRUG; [6 METHOXY 2 (4 METHOXYPHENYL)BENZO[B]THEIN 3 YL](4 CYANOPHENYL)METHANONE;

ARTICLE; DRUG EFFECT; MALE; NONHUMAN; PRESSURE TRANSDUCER; RAT; RECEPTOR BINDING; STATISTICAL ANALYSIS; VASODILATATION;

EID: 0033036259     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005322     Document Type: Article

References (23)

1. 1 receptors and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br J Pharmacol 123:968-974
2. Deutsch DG, Goligorsky MS, Schmid PG, Krebsbach RJ, Schmid HHO, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G, Moore LC (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100:1538-1546
3. Felder CC, Joyce KE, Broely EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA, Brownstein M (1998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation cAMP accumulation. J Pharmacol Exp Ther 284:291-297
4. Garland CJ, Plane F, Kemp BK, Cocks TM (1995) Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci 16:23-30
5. Hewitt N, Plane F, Garland CJ (1997) Bioassay of EDHF in the rabbit isolated femoral artery. Br J Pharmacol 122:122P
6. Landsman RS, Makriyannis A, Deng H, Consroe P, Roeske WR, Yamamura HI (1998) AM630 is an inverse agonist at the human cannabinoid CB1 receptor. Life Sci 62:109-113
7. 2 receptors. Br J Pharmacol 124:619-622
8. McCulloch AI, Randall MD (1996) Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed. Br J Pharmacol 117:859-866
9. McCulloch AI, Bottrill FE, Randall MD, Hiley CR (1997) Characterisation and modulation of EDHF-mediated relaxations in the rat isolated superior mesentric arterial bed. Br J Pharmacol 120:1431-1438
10. 2 receptors. Pharmacol Ther 74:129-180
11. Plane F, Holland M, Waldron GJ, Garland CJ, Boyle JP (1997) Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br J Pharmacol 121:1509-1512
12. Pratt PF, Hillard CJ, Edgemond WS, Campbell WB (1998) N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol 274:H375-H381
13. Randall MD (1997) EDHF: is the answer a cannabinoid? Br J Pharmacol 122:445P
14. Randall MD, Hiley CR (1988) Effect of phenobarbitone pretreatment upon endothelium-dependent relaxation to acetylcholine in rat superior mesenteric arterial bed. Br J Pharmacol 94:977-983
15. Randall MD, Kendall DA (1998) Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol Sci 19:55-58
16. Randall MD, Alexander SPH, Bennett T, Boyd EA, Fry, JR, Gardiner SM, Kemp PA, McCulloch AI, Kendall DA (1996) An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun 229:114-120
17. Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Breliere JC, LeFur G (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 284:644-650
18. Rowe DTD, Garland CJ, Plane F (1998) Multiple pathways underlie NO-independent relaxation to the calcium ionophore A23187 in the rabbit isolated femoral artery. Br J Pharmacol 123:1P
19. Sedhev J, Garland CJ, Plane F (1998) Further characterisation of the mediator of NO-independent dilatation to acetylcholine in the rat isolated perfused mesenteric bed. Br J Pharmacol 123:2P
20. Sugiura T, Kodaka T, Nakane S, Kishimoto S, Kondo S, Waku K (1998) Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator. Biochem Biophys Res Commun 243:838-843
21. White R, Hiley CR (1997a) A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol 122:1573-1584
22. White R, Hiley CR (1997b) Endothelium and cannabinoid receptor involvement in levcromakalim vasorelaxation. Eur J Pharmacol 339:157-160
23. Zygmunt PM, Högestatt ED, Waldeck K, Edwards G, Kirkup AJ, Weston AH (1997) Studies on the effects of anandamide in the rat hepatic artery. Br J Pharmacol 122:1679-1686